About Human C-X-C Chemokine Receptor Type 4 (CXCR4) Stable Cell Line

C-X-C Chemokine Receptor Type 4 (CXCR4), also known as CD184, is a Class A G protein-coupled receptor (GPCR) that serves as the primary receptor for the chemokine CXCL12, also known as stromal cell-derived factor-1 (SDF-1). CXCR4 is widely expressed in hematopoietic cells, immune cells, endothelial cells, stem cells, and numerous other tissues, where it regulates cell migration, homing, survival, proliferation, and tissue development. Upon activation by CXCL12, CXCR4 primarily couples to Gi proteins, resulting in inhibition of adenylate cyclase, intracellular calcium mobilization, activation of MAPK and PI3K/Akt signaling pathways, and modulation of cellular chemotactic responses.

CXCR4 is one of the most extensively studied chemokine receptors because of its critical roles in immune function, stem cell trafficking, embryonic development, cancer metastasis, and viral infection. The CXCL12-CXCR4 signaling axis controls hematopoietic stem cell homing to the bone marrow and regulates leukocyte migration during immune responses. Dysregulation of CXCR4 signaling has been implicated in numerous diseases, including leukemia, lymphoma, solid tumors, inflammatory disorders, autoimmune diseases, and HIV infection. Notably, CXCR4 functions as a major co-receptor for T-cell-tropic HIV-1 strains, making it an important target for antiviral research and therapeutic development.

eEnzyme's Human CXCR4 Stable Cell Line provides a reliable and reproducible cellular platform for investigating CXCR4-mediated signaling pathways and evaluating receptor-targeted therapeutics. The cell line enables quantitative assessment of agonists, antagonists, antibodies, peptides, and small-molecule modulators through calcium mobilization assays, reporter gene assays, chemotaxis studies, and other GPCR functional screening platforms. Researchers can utilize this stable cell line for receptor characterization, compound profiling, lead optimization, and high-throughput screening applications supporting oncology, immunology, stem cell biology, and infectious disease research.

Applications of the CXCR4 Stable Cell Line

• CXCR4 receptor pharmacology studies
• CXCL12 (SDF-1) signaling investigations
• Cancer metastasis and tumor microenvironment research
• HIV entry and antiviral drug discovery studies
• Stem cell homing and mobilization research
• Antibody and small-molecule screening
• Calcium mobilization and GPCR signaling assays
• High-throughput screening applications

Biological Significance of CXCR4

CXCR4 is a master regulator of cellular migration and tissue homing. Through interaction with its ligand CXCL12, the receptor directs the trafficking of hematopoietic stem cells, immune cells, and progenitor cells throughout the body. In oncology, aberrant CXCR4 expression is frequently associated with tumor progression, angiogenesis, metastasis, therapeutic resistance, and poor clinical outcomes. In infectious disease research, CXCR4 serves as an essential co-receptor for HIV-1 entry into host cells, making it a clinically validated therapeutic target. The CXCL12-CXCR4 signaling axis is also critical for embryonic development, cardiovascular biology, tissue repair, and immune system organization. Because of its broad physiological importance and therapeutic relevance, CXCR4 remains one of the most important chemokine receptors in cancer biology, immunology, stem cell research, and drug discovery. The CXCR4 Stable Cell Line provides a valuable tool for studying receptor function and advancing the development of CXCR4-targeted therapeutics.